Merck Kgaa MERCK ORD SHS/  DE0006599905  /

London International
12/2/2020  7:10:34 PM Chg. +1.30 Volume Bid12/2/2020 Ask12/2/2020 Market Capitalization Dividend Y. P/E Ratio
135.63EUR +0.97% 107,124
Turnover: 1.58 mill.
133.80Bid Size: 5,000 136.55Ask Size: 5,000 17.49 bill.EUR 0.96% 44.51

Business description

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Management board & Supervisory board

CEO
Dr. Stefan Oschmann
Management board
Marcus Kuhnert, Belén Garijo, Dr. Kai Beckmann
Supervisory board
Dr. Wolfgang Büchele, Alexander Putz, Anne Lange, Christian Raabe, Daniel Thelen, Dietmar Oeter, Edeltraud Glänzer, Gabriele Eismann, Helene von Roeder, Helga Rübsamen-Schaeff, Jürgen Glaser, Michael Kleinemeier, Peter Emanuel Merck, Renate Koehler, Sascha Held, Simon Thelen
 

Company data

Name: Merck KGaA
Address: Frankfurter Str. 250,D-64293 Darmstadt
Phone: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 67.13%
IPO date: 10/20/1995

Investor relations

Name: Constantin Fest
IR phone: +49-6151-72-3321
IR Fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Company calendar

CW 10 | 3/4/2021 Financial Statement Press Conference
CW 10 | 3/4/2021 4th Quarter/Annual Report
CW 17 | 4/23/2021 General Shareholder Meeting
CW 20 | 5/12/2021 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Freefloat
 
67.13%
BlackRock, Inc.
 
5.00%
DWS Investment GmbH
 
3.97%
State Street Corporation
 
3.00%
Sun Life Financial
 
3.00%
Deutsche Bank
 
3.00%
The Vanguard Group, Inc.
 
3.00%
Crédit Agricole S.A
 
3.00%
Templeton Global Advisors Limited
 
2.98%
Others
 
5.92%